Zobrazeno 1 - 10
of 140
pro vyhledávání: '"John Sweetenham"'
Autor:
Victoria Hood, Lindsey Bandini, Taneal Carter, Alyssa Schatz, John Sweetenham, Warren Smedley, Joanna Fawzy Morales, Rebecca V. Nellis, Randy A. Jones, Lynn Zonakis, Robert W. Carlson
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:459-464
Survival rates for people with cancer and quality of life for survivors have increased significantly as a result of innovations in cancer treatment, improvements in early detection, and improved healthcare access. In the United States, 1 in 2 men and
Autor:
P. Abena Anyidoho, Claire F. Verschraegen, Merry Jennifer Markham, Steven Alberts, John Sweetenham, Kendra Cameron, Taher Abu Hejleh
Publikováno v:
JCO Oncology Practice. 19:e706-e713
PURPOSE: The 21st Century Cures Act mandates the immediate release of clinical information (IRCI) to patients. Immediate sharing of sensitive test results to patients with cancer might have serious unintended consequences for patients and providers.
Autor:
Kavitha Nair, Charlene Stein, Rebecca Stephens, Kyle Taylor, John Sweetenham, Salwan Al Mutar, Connor Campbell
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:QIM23-143
Autor:
John, Sweetenham
Publikováno v:
Journal of the National Comprehensive Cancer Network. 20:1074-1075
Autor:
Jane Ostler, Janae Decker, Lisa Anderson, John Sweetenham, Nathan Begaye, Garrett Harding, Susana Alba, Donna Branson, Allison Whitworth, Ana Maria Lopez, Jeff Yancey, Allison Elmer, Hannah Holm, Alyssa Geisler, Victoria Meade, Jennyffer Morales
Publikováno v:
Cancer Epidemiology, Biomarkers & Prevention. 29:A061-A061
In 2016, the National Cancer Institute (NCI)'s Center to Reduce Cancer Health Disparities (CRCHD) launched Screen to Save: Colorectal Cancer Outreach and Screening Initiative (S2S). The initiative's primary goal aligned with Blue Ribbon Panel Cancer
Autor:
Ronald Sobecks, Jerome B. Zeldis, Matt Kalaycio, Janice Reed, Aleksandr Lazaryan, Steven Andresen, Rachid Baz, Kimberly Hamilton, Beth Faiman, Mary Ann Karam, Joel Waksman, Gordan Srkalovic, Frederic J. Reu, John Sweetenham, Robert M. Dean, Robert Knight, Becky Habecker, Kellie Bruening, Mohamad A. Hussein
Publikováno v:
American Journal of Hematology. 89:349-354
A previous interim report of MM-011, the first study that combined lenalidomide with anthracycline-based chemotherapy followed by lenalidomide maintenance for relapsed and/or refractory multiple myeloma (RRMM), showed promising safety and activity. W
Publikováno v:
Ophthalmology. 121:334-341
Objective To describe the clinical features, ancillary diagnostic studies, and treatment selection in a cohort of patients with uveal lymphoma. Design Retrospective clinical review. Participants A total of 22 patients (34 affected eyes) diagnosed wit
Publikováno v:
Ophthalmology. 120:1915-1919
Purpose To assess distribution, correlations, and prognostic effect of tumor (T), node (N), and metastasis (M) staging on relapse and survival. Design Retrospective clinical review. Participants Sixty-three patients diagnosed with primary ocular adne
Publikováno v:
Leukemia & Lymphoma. 54:2299-2302
Four variants of Kaposi sarcoma (KS) have been recognized: classic, endemic, epidemic or acquired immune deficiency syndrome (AIDS)-associated, and immunosuppression- or transplant-associated KS [1...
Autor:
John Sweetenham, Craig A. Portell
Publikováno v:
The Cancer Journal. 18:432-438
Adult lymphoblastic lymphoma (LBL) is an aggressive form of non-Hodgkin lymphoma occurring in predominantly adolescent and young adult men. Lymphoblastic lymphoma is rare, accounting for 1% to 2% of all non-Hodgkin lymphomas and is of T-cell phenotyp